CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.

Jeanette Lundin, Håkan Mellstedt, Roel Willemze et al.|Journal of Clinical Oncology|1998

Cited by 258